Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Royalty Pharma Plc
RPRXCurrent price
27.73 USD
+0.03 USD (+0.11%)
Last closed
27.6 USD
Company
www.royaltypharma.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
16 124 280 832 USD
Yield for 12 month
-6.57 %
1Y
3Y
5Y
10Y
15Y
RPRX
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. Address: 110 East 59th Street, New York, NY, United States, 10022
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
44.83 USDP/E ratio
18.1133Dividend Yield
3.06 %Current Year
+2 354 554 000 USD
Last Year
+2 237 215 000 USD
Current Quarter
+537 267 000 USD
Last Quarter
+567 978 000 USD
Current Year
+1 793 898 000 USD
Last Year
+2 231 545 000 USD
Current Quarter
+531 267 000 USD
Last Quarter
-15 622 000 USD
Key Figures RPRX
1 year
3 years
5 years
10 years
EBITDA
1 497 820 032 USD
Operating Margin TTM
PE Ratio
18.1133
Return On Assets TTM
3.45 %
PEG Ratio
19.353
Return On Equity TTM
10.53 %
Wall Street Target Price
44.83 USD
Revenue TTM
2 237 626 112 USD
Book Value
14.42 USD
Revenue Per Share TTM
Dividend Share
0.82 USD
Quarterly Revenue Growth YOY
-0.2 %
Dividend Yield
3.06 %
Gross Profit TTM
1 332 971 000 USD
Earnings per share
1.5 USD
Diluted Eps TTM
1.5 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-55.2 %
Profit Margin
30.09 %
Dividend Analytics RPRX
Dividend growth over 5 years
–Continuous growth
3 yearsPayout Ratio 5 years average
279 %Dividend History RPRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.84
Ex Dividend Date
16.08.2024
Forward Annual Dividend Yield
3.06 %
Last Split Factor
–
Payout Ratio
21.39 %
Last Split Date
–
Dividend Date
13.09.2024
Stock Valuation RPRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
18.1133
Forward PE
11.8064
Enterprise Value Revenue
7.6977
Price Sales TTM
7.206
Enterprise Value EBITDA
14.1614
Price Book MRQ
1.8801
Financials RPRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RPRX
For 52 weeks
25.01 USD
31.18 USD
50 Day MA
27.16 USD
Shares Short Prior Month
16 486 571
200 Day MA
28.16 USD
Short Ratio
6.11
Shares Short
14 872 921
Short Percent
3.44 %
BeatStart